Companion diagnostics are strengthening big pharma's personalized medicine pipeline
This event is dedicated to fostering a meeting platform and cover all the aspects of this complex endeavor, with the ultimate goal of taking product development to the next level.
Move from Blockbuster to Nichebuster. It is a Do or Die.
Personalized & Translational Medicine Summit 2010 addresses the big issues. It will bring together all stakeholders in personalized medicine. More than 22 senior level speakers from the pharmaceutical and diagnostics industry will give insights into their biggest challenges and develop ways to overcome them. This platform will foster the collaboration between drug and diagnostics development and generate practical solutions for all stakeholders.
What you'll take away from this meeting:
This conference will be different
Andy Dorner, Senior Director of Molecular Medicine at Millennium gives a preview on his talk in our podcast:
This meeting will not be a best practice conference with standard speaking slots and power point presentations. Yes, we have leading thinkers in this space on our speaker panel – but delegates in attendance will be as much a part of the meeting as these speakers.
Discussion, debate and scrutiny will be the order of the meeting. This is your chance to be part of an initiative to test theories, discuss successful models and forge new collaborations.
No-one can afford to ignore this trend ... it's the future of pharma.